
GC33522
4-Hydroxymephenytoin
Also known as 5-ethyl-5-(4-hydroxyphenyl)-3-methylimidazolidine-2,4-dione
4-Hydroxymephenytoin is the major metabolite of mephenytoin in the human body catalyzed by CYP2C19, an anti-epileptic drug and a typical substrate of CYP2C19
ChemicalCAS61837-65-8MW234.26FormulaC12H14N2O3
- CAS number
- 61837-65-8
- Molecular weight
- 234.26
- Formula
- C12H14N2O3
- Solubility
- DMF: 25 mg/ml,DMSO: 25 mg/ml,DMSO:PBS (pH 7·2) (1:1): 0·5 mg/ml,Ethanol: 15 mg/ml
- InChIKey
- OQPLORUDZLXXPD-UHFFFAOYSA-N
- Catalogue number
- GC33522
- Brand
- GLPBIO
Computed properties PubChem CID 119507 · XLogP 1.2 · TPSA 69.6 Ų · H-bond donors 2
- XLogP
- 1.2
- TPSA
- 69.6 Ų
- H-bond donors
- 2
- H-bond acceptors
- 3
- Rotatable bonds
- 2
- Heavy atoms
- 17
SMILES CCC1(C(=O)N(C(=O)N1)C)C2=CC=C(C=C2)O
Computed descriptors from PubChem (CID 119507), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il